- Cellectis complète l’annonce des modalités définitives de son offre d’ADS avec la répartition de son capital après la réalisation de son offre d’ADS
- Cellectis Supplements the Announcement of the Pricing of Follow-On Offering with Allocation of Share Capital Information
- Cellectis annonce les modalités définitives de son offre d’ADS
- Cellectis Announces Pricing of Follow-On Offering
- Cellectis Announces Launch of Follow-On Offering
- Cellectis annonce le lancement d’une nouvelle offre d’ADS
- Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
- Cellectis modifie sa note convertible de 20 millions de dollars dans le cadre de l’accord de collaboration avec son partenaire Cytovia Therapeutics
- Calyxt et Cibus annoncent la signature d’un Accord de Fusion
- Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement
More ▼
Key statistics
On Friday, Cellectis SA (ZVAA:STU) closed at 2.14, 40.79% above the 52 week low of 1.52 set on Dec 30, 2022.
52-week range
Markit short selling activity
Open | 2.42 |
---|---|
High | 2.42 |
Low | 1.99 |
Bid | 2.16 |
Offer | 2.46 |
Previous close | 2.86 |
Average volume | 0.00 |
---|---|
Shares outstanding | 45.68m |
Free float | 45.57m |
P/E (TTM) | -- |
Market cap | 118.60m USD |
EPS (TTM) | -2.29 USD |
Data delayed at least 15 minutes, as of Feb 03 2023.
More ▼